Abstract
Enzymatic and non-enzymatic oxidation of unsaturated fatty acids gives rise to reactive species that covalently modify nucleophilic residues within redox sensitive protein sensors in a process called lipoxidation. This triggers adaptive signaling pathways that ultimately lead to increased resistance to stress. In this graphical review, we will provide an overview of pathways affected by protein lipoxidation and the key signaling proteins being altered, focusing on the KEAP1-NRF2 and heat shock response pathways. We review the mechanisms by which lipid peroxidation products can serve as second messengers and evoke cellular responses via covalent modification of key sensors of altered cellular environment, ultimately leading to adaptation to stress.
Abbreviations: ABPP, Affinity based protein profiling; aLA, Alkyne-labeled linoleic acid; ARE, Antioxidant response element; BTB, Broad complex, Tram-track, and Bric-a-Brac; CTAD, C-terminal transactivation domain; CTD, C-terminal domain; CUL3, (Cullin-3)-ubiquitin E3 ligase complex; DBD, DNA binding domain; DMSO, Dimethyl sulfoxide; GCLC, Glutamate cysteine ligase catalytic; GCLM, Glutamate-Cysteine Ligase Modifier Subunit; G-REX, Genome-wide variant of T-REX; GST, Gluthathione S-transferase; HSE, Heat shock element; HSF1, Heat shock factor 1; HSP, Heat shock protein; HSR, Heat shock response; HSPA8, Heat shock protein family A (Hsp70) member 8; HSPD1/E1, Heat shock protein family D/E (Hsp60/Hsp10) member 1; HSP40, 40-kDa heat shock proteins from HSP40 family; HSP70, 70-kDa heat shock proteins from HSP70 family; HSP90, 90-kDa heat shock proteins from HSP90 family; H2O2, Hydrogen peroxide; IA, Iodoacetamide alkyne; IER5, Immediate early response 5; IVR, Intervening region; KEAP1, Kelch-like ECH-associated protein 1; LC-MS, Liquid chromatography-mass spectrometry; LDE, Lipid-derived electrophiles; LNO2, 9-, 10-, 12-, or 13-nitro-octadeca-9, 12-dienoic acid; LOX12/15, 12/15-Lipoxygenase; LZ1–3, Leucine zipper 1–3 domains; LZ4, Leucine zipper 4 domain; MD, Middle domain; MS, Mass spectrometry; MRP, Multidrug-resistance-associated protein; Neh, Nrf2-ECH homology; NO2-CLA, nitro-conjugated linoleic acid; NRF2, NF-E2-related factor 2; NTD, N-terminal domain; NTR, N-terminal region; NQO1, NAD(P)H:quione oxidoreductase 1; OA-NO2, Nitro-oleic acid; oxPAPC, Oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine; PARP1, Poly(ADP-ribose) polymerase 1; PARP13, Poly(ADP-ribose) Polymerase 13; PEIPC, 1-palmitoyl-2-(5, 6)-epoxy isoprostane E2)-sn-glycero-3-phosphocholine; PGA2, Prostaglandin A2; POLK, DNA polymerase kappa; PRDX1, Peroxiredoxin 1; RD, Regulatory domain; RES, Reactive electrophilic species; ROS, Reactive oxygen species; SILAC, Stable isotope labeling with amino acids in cell culture; SH, sulfhydryl group; sMAF, small musculoaponeurotic fibrosarcoma oncogene homolog protein family; SQSTM1, Autophagosome cargo protein Sequestosome 1; TEV, Tobacco etch virus; T-REX, Targetable reactive electrophiles and oxidants; TXNR1D1, Thioredoxin reductase 1; Ub, ubiquitin; ZAK, Animal-specific MAP kinase found in stress responses; 4-HNE, 4-hydroxy-2-nonenal; 15d-PGJ2, 15-deoxy-Δ-12,14-prostaglandin J2
Keywords: Redox regulation, Protein lipoxidation, Stress response, NRF2, KEAP1, HSF1, Heat shock proteins, Cysteine modification
Graphical abstract
1. Introduction
Post-translational regulation of signaling proteins via oxidation-reduction (redox) status of certain amino acids, cysteines in particular, has expanded our understanding of the role of reactive oxygen species mediating cellular signaling events in cells [1]. Oxidation of thiol residues within proteins to yield multiple oxidative states or disulfide formation by hydrogen peroxide (H2O2) has been widely studied, but the concept has now expanded to include thiol reactions with reactive electrophilic species formed e.g. via enzymatic and non-enzymatic oxidative reactions with unsaturated fatty acids [2], [3]. In this graphical review, we provide a brief overview of the key adaptive pathways responsive to stress elicited by lipoxidation products (Fig. 1), the thiol targets of lipid-derived electrophiles (LDEs) identified in signaling proteins, as well as introduce novel methods to identify additional targets for lipid-derived electrophiles. Specifically, this review will focus on KEAP1-NRF2 and HSF1 pathways and highlights the protein targets modified by lipoxidation affecting these pathways.
Fig. 1.
Activation of the KEAP1-NRF2 and HSF1 pathways by electrophilic lipoxidation products. To survive, cells have developed an intricate set of stress signaling pathways that are activated by endogenous or exogenous signals [63]. Central to these defenses are the KEAP1-NRF2 and HSF1 pathways that together regulate hundreds of genes via binding to antioxidant response and heat shock elements, respectively [64], [65]. A) The main signaling proteins of KEAP1-NRF2 pathway are the transcription factor NRF2 and its negative regulator protein KEAP1, which is a cullin-3 (CUL3)-RING ubiquitin ligase adaptor/scaffold protein enabling rapid proteasomal degradation of NRF2 during unstressed conditions. NRF2 is bound by the BTB domains of the KEAP1 dimer via DLG and ETGE motifs residing in NRF2 Neh2 domain. During the activation by e.g. lipid-derived electrophiles, the proteasomal degradation machinery is disrupted and de novo synthetized NRF2 is free to enter the nucleus to heterodimerize with the members of the musculoaponeurotic fibrosarcoma oncogene homolog protein family (sMAF) and drive the expression of cytoprotective genes [66]. SH; Sulfhydryl group of free cysteine residue, Ub; Ubiquitin. B) The HSF1 pathway consists of inactive HSF1 monomer that is bound by heat shock proteins from HSP90α [67] and HSP70 [68] families. HSF1 is negatively regulated by HSPs [69]. During stress, the interaction is disrupted and HSF1 trimerizes and enters the nucleus to regulate the heat shock response genes [70]. While the two pathways are largely distinct, they converge at the level of shared stimulus (e.g. electrophilic lipid peroxidation products) and mode of action (i.e. modification of redox-active cysteines that are regarded as molecular “switches”) [63].
2. Stress signaling by lipoxidation
Oxidation of polyunsaturated fatty acids generate different electrophilic lipoxidation products. These electrophilic products derived from lipids can interact with nucleophilic protein residues covalently through Michael addition reaction, leading to conformational changes in proteins that can affect their function [4]. Some target proteins that can be modified by the interaction with electrophilic lipids are transcription factors, proteins involved in cell defense, enzymes (such as glutathione S-transferase, GST) and regulators of signaling pathways (such as RAS) [4], [5]. Importantly, electrophilic lipids exert biphasic effects, low concentrations being able to elicit adaptive cell signaling pathways that are cytoprotective and anti-inflammatory, while higher concentrations can aggravate inflammation and cause cell death. These effects depend not only on the concentration but also the cell type being affected, as well as the chemical nature of the lipid species [2], [6], [7].
Several stress-activated pathways are key targets for regulation by lipoxidation. These include the antioxidant response pathway governed by the KEAP1-NRF2-system [8] and the heat shock response via HSF transcription factors [9], that are in the focus of this review. However, protein lipoxidation can also affect stress kinase pathways, as kinases, phosphatases and/or their regulators can be targeted by lipoxidation [10]. Affected pathways include the c-Jun N-terminal kinase (JNK) pathway, as well as the structurally similar p38 pathway, which belong to the mitogen-activated protein kinase cascades. These pathways regulate e.g. differentiation, motility and apoptosis [2], [11], and can be modulated by LDEs such as 4-HNE and cyclopentenone prostaglandins [10], [12].
3. Activation of the KEAP1-NRF2 signaling pathway by lipid-derived electrophiles
The KEAP1-NRF2 pathway (Fig. 1A), is the key pathway mediating the transcriptional response to oxidative and electrophilic stress [13]. Under unstressed conditions, the transcription factor NRF2 (NF-E2-related factor 2) is tethered by KEAP1 (Kelch-like ECH-associated protein 1), an adaptor protein within the CUL3 (cullin-3)-ubiquitin E3 ligase complex, resulting in proteasomal degradation of NRF2 via the 26S proteasome [8], [14], [15]. NRF2 binds to KEAP1 via two different and highly conserved motifs present in Neh2 domain: a weak affinity, DLG motif and a high affinity, ETGE motif (Fig. 1 A). Upon exposure to stimuli, ubiquitination is disrupted and newly synthetized NRF2 translocates to the nucleus, where it binds to the antioxidant response element (ARE) within the regulatory regions of NRF2 dependent genes driving their expression [13], [16].
KEAP1 has four functional domains: Bric-a-Brac, tram-track, broad complex (BTB) domain, the intervening region (IVR), the Kelch domain and the C-terminal region. [13] The human KEAP1 protein contains altogether 27 cysteine residues, of which three have unambiguously shown to have functional importance (Fig. 2A) [17], [18]. These are Cys151 in BTB domain and Cys273 and Cys288 in the IVR region [13], [19].
Fig. 2.
Cysteine residues are critical mediators of the antioxidant and heat shock responses. A) In the KEAP1-NRF2 pathway, the KEAP1 protein is responsible for sensing oxidant/electrophile stress. Human KEAP1 has 27 cysteines in total, enriched in the IVR-domain [17], [18]. Cysteine modification leads to conformational changes in KEAP1, resulting in disruption of KEAP1-mediated ubiquitination of NRF2 [71]. B) There are seven cysteine residues in human NRF2, implicated to take part in oxidant/electrophile sensing [72]. However, no studies have addressed their impact on LDE-mediated NRF2 activation. C) Human HSF1 contains five cysteines, two of which (C35 and C135) have been shown to form a dimer upon heat stress or by H2O2[73], [74]. However, no studies to date have identified LDE targets in HSF1. D) Molecular chaperone family of HSP70s are one of the more abundant HSPs that regulate HSF1 [75], [76]. HSP70s have five cysteines. E) Human HSP90α family of HSPs contain seven cysteines that are reactive towards heat shock and oxidative stress [73], [77].
LDEs are produced endogenously by both enzymatic and non-enzymatic reactions from unsaturated fatty acids [2], [20]. Given their electrophilic character, they are able to activate NRF2 in a KEAP1-dependent manner. With respect to the mechanism of activation, arachidonic acid-derived cyclopentenone prostaglandins and isoprostanes (prostaglandin A2, PGA2; 15-deoxy-Δ-12,14-prostaglandin J2, 15d-PGJ2 and structurally similar cyclopentenone isoprostanes produced by nonenzymatic oxidation), lipid-derived aldehydes, especially 4-hydrononenal (4-HNE), and nitroalkenes (nitro-oleic acid, OA-NO2; nitrolinoleic acid, LNO2; nitro-conjugated linoleic acid, NO2-CLA) have been studied in some detail. There are discrepant findings of KEAP1 and NRF2 thiols that are modified by LDEs (Fig. 2A,B and Table 1). Particularly in the case of 15d-PGJ2, PGA2 and OA-NO2, it is clear that C151 in KEAP1 is not the primary target unlike with C151-preferring activators such as cyclic cyanoenones, some of which are currently in clinical stages of drug development [21]. In addition to free oxidized lipid species, oxidized phospholipids can activate NRF2 [22], [23], [24]. 1-palmitoyl-2-(5,6-epoxy isoprostane E2)-sn-glycero-3-phosphocholine (PEIPC), the major active component of oxidized 1-palmitoyl-2-arachidonoyl-sn-Glycero-3-phosphorylcholine (oxPAPC), has been shown to activate NRF2 in a thiol-dependent manner, but the mechanism of action and thiol targets are currently unknown [22], [23].
Table 1.
Cysteine targets of LDEs. The compound abbreviations: 10-nitro-octadec-9-enoic acid (OA-NO2), prostaglandin A2 (PGA2), 4-hydroxynonenal (4-HNE), and 15-deoxy-Δ-12,14-prostaglandin J2 (15d-PGJ2) [19], [40], [41], [81], [82], [109].
![]() |
4. Lipoxidation targets of the HSF1 pathway
Heat shock response (HSR) is an evolutionarily conserved pathway that has evolved to provide protection to eukaryotic cells against heat, oxidative and other forms of proteotoxic stress [9], [25]. HSR includes a sequence of events in which heat shock proteins (HSPs), acting as molecular chaperones and heat shock factors 1 and 2 (HSF1 and 2), transcription factors mediating transcriptional responses coordinate to maintain protein homeostasis in affected cells [26]. Though there are different HSF family members (HSF1–4 in mammals), HSF1 is the factor primarily orchestrating protein homeostasis [27], [28]. HSR (Fig. 1B) is a transcriptional response, where HSF1 binds to DNA to regulate transcription of hundreds of genes including a number of HSPs [29]. Under basal conditions, HSF1 is bound to an inhibitory complex consisting of HSP40, HSP70 and HSP90 existing only as latent and transcriptionally inactive monomer in the cytoplasm [30], [31]. During HSR, HSF1 is released from the complex and it forms transcriptionally active trimer by binding to two other HSF family members via hydrophobic repeats in leucine zipper (LZ1–3 and LZ4) domains [32]. After trimerization, the complex translocates to the nucleus and utilizing specialized DNA binding domains the trimer binds to heat shock elements (HSE) that contain conserved inverted repeats of nGAAn pentamers to regulate transcription [27], [33]. Along with post-translational modifications such as sumoylation, phosphorylation and acetylation, electrophilic adduction of cysteine amino acid residues by LDEs can also regulate the activity of HSF1 and HSPs (Fig. 2C,D,E) [34], [35].
It has long been known that LDEs can trigger HSR in cells. One of the earliest reports found that cyclopentenone prostaglandins PGA2 and 15d-PGJ2 increase the expression of inducible HSP70, the key marker of HSR in K562 erythroleukemia cells [36] and later on, other LDEs such as 4-HNE and OA-NO2 have been shown to evoke HSR in an HSF1 dependent manner [34], [37], [38]. Though the exact mechanism by which HSF1 is activated by LDEs is not well understood at the moment, it is widely believed that LDEs target cysteines within HSPs resulting in HSF1 release and activation [2], [38]. Other mechanisms contributing to the modulation of this pathway by LDEs, include the lipoxidation of histone deacetylases which affects the expression of HSP70 [39]. Cysteine residues, C572 and C267 respectively, of rat HSP90 and HSP70 are modified by 4-HNE (Figs. 2D,E and 3) [40], [41]. HSF1 has also been shown to contain redox-sensitive cysteines, as a disulfide bridge can be formed between C35 and C105 in recombinant human HSF1 upon exposure to heat shock or H2O2 [42] (Fig. 2C). However, their role in LDE-mediated HSR is not known. In addition to cysteine modifications, also histidine residues in HSP90α and β proteins can be modified by 4-HNE oxidation: targeted purification and mass spectrometry analysis in human colorectal cancer cells identified H450 and H442 to be adducted in HSP90α and β, respectively [43]. In addition, both HSP70 and Hsp90 have been shown to be modified with cyclopentenone prostaglandins, 15d-PGJ2 and or PGA2 [44], [45], [46].
Fig. 3.
Targets of LDEs in the KEAP1-NRF2 and HSF1 pathways. The ability of LDEs to activate cell signaling pathways depend on their reactivity with sulfhydryl groups. Lipoxidation is a process that does not affect cellular proteins randomly as it is directed by the differences in the binding strength, pKa, type of the Michael acceptors, shape of the electrophilic molecule, and the presence of other amino acids close to the reactive cysteine [19], [23], [40], [41], [78], [79], [80], [81], [82], [83]. Modification of thiol targets elicit downstream transcriptional responses that alleviate oxidant and proteotoxic stress [84]. NRF2 encodes a myriad of antioxidant genes by binding to highly conserved ARE sites within enhancer regions of genes after forming a heterodimer with a small MAF protein in the nucleus [85]. The highly conserved NRF2 target genes providing protection against xenobiotics include NAD(P)H:quinone oxidoreductase 1 (NQO1) [86], [87], [88], [89], Phase II enzyme Glutathione S-transferase (GST) [90] and Multidrug-resistance-associated proteins (MRPs) [91]. Additionally, NRF2 regulates gene expression of enzymes involved in glutathione metabolism as well as antioxidants. These include glutamate-cysteine ligase catalytic (GCLC) [92] and modifier (GCLM) subunits [93], thioredoxin reductase 1 (TXNRD1) [94] and antioxidant enzymes from peroxiredoxin family (e.g. PRDX1) [95], [96]. NRF2 also encodes autophagosome cargo protein sequestome 1 (SQSTM1), which binds other proteins for specific autophagy [97]. Upon activation of the heat shock response, HSF1 forms first an active trimer and activating genes having a HSE regulatory element, such as immediate early response 5 (IER5) [97] and multiple heat shock proteins (chaperones) that have various different functions. These genes include heat shock protein family A (HSP70) member 8 (HSPA8) [98], Heat shock protein family D/E (HSP60/HSP10) member 1 (HSPD1/E1) [99], 40-kDa heat shock proteins from HSP40 family (HSP40) [100]. HSF1 can also provide the means to repair already damaged DNA by encoding DNA polymerase kappa (POLK) [101] and through a complex with Poly(ADP-ribose) polymerase 1 and 13 (PARP1 and PARP13) [102], [103], [104]. KEAP1-NRF2 and HSF1 pathways co-activate and/or regulate heme oxygenase 1 (HMOX1). Both pathways are thus complementary and overlapping in their functions [105], [106], [107], [108].
5. Novel methods to identify cysteine targets of lipoxidation
Identification of novel signaling pathways affected by protein lipoxidation warrants the use of unbiased methods to identify target proteins in a manner that allows quantitative analysis of thiols that are most sensitive to electrophilic adduction. The well-established methods used to detect thiol modification by LDEs have been comprehensively reviewed by Aldini et al. [47], [48]. The methods available include direct detection and quantitation of LDE-protein adducts from experimental or clinical samples by label-free mass spectrometry (MS) approaches, as well as detection of modified proteins by antibodies recognizing LDE-protein adducts such as 4-HNE-modified proteins [10], [49], tagging methods such as biotinylated analogs of cyPGs [49], [50], as well methods utilizing “click” chemistry [51], [52]. These methods to capture LDE-modified proteins can be then coupled with high resolution mass spectrometry (MS) for identification of protein targets [48].
For a more quantitative analysis of protein targets, Wang et al. have developed an affinity based protein profiling (ABPP) method using isotope-labeling for quantifying the reactivity of 4-HNE and 15d-PGJ2 in the human proteome [53]. In this approach, human breast cancer cells were first treated with LDEs or DMSO (control), followed by alkynylated iodoacetamide (IA) probe, and conjugated by copper-catalyzed azide-alkyne cycloaddition (“click”) chemistry to light and heavy protease–cleavable biotin tags. After enrichment with streptavidin and sequential on-bead protease digestions, the probe-labeled peptides were analyzed by liquid chromatography–tandem mass spectrometry (LC-MS/MS). (Fig. 4A) [53]. This approach showed differential reactivity of LDEs with redox sensitive cysteines in proteome, and allowed identification of novel targets such as active site cysteine within ZAK kinase modified by 4-HNE [53].
Fig. 4.
Emerging novel methods to identify thiol targets of LDEs. A) In competitive activity-based profiling method with isotope labeling, cells are treated with DMSO or LDE, after which the proteins are labeled with an iodoacetamide alkyne probe and isotopically-labeled, TEV protease-cleavable biotin tags are incorporated with click chemistry. After enrichment with streptavidin, sequential on-bead protease digestion is done to yield probe-labeled peptides for MS analysis. B) T-REX (Targetable reactive electrophiles and oxidants) assisted RES delivery utilizes RES linked signaling molecules to increase on-target signaling output [54], [58]. Unlike conventional methods of dosing, where the cells are exposed to extracellular RES dosing, T-REX method aims to limit the activation of multiple signaling pathways simultaneously. This is achieved with functional Halo-fusion protein complexes expressed by the live cell, which are activated via photo-uncaging to release the RES [56]. Identification of cysteine targets is performed from the cell lysate using LC-MS. POI; protein of interest. C) G-REX (Genome-Wide reactive electrophiles and oxidants) is a high-throughput version of T-REX that achieves similar results while utilizing cell lines that express only HaloTag [56]. The cells are subsequently treated with specifically designed photocaged probes before MS-analysis of total proteome. D) To identify targets of endogenously produced LDEs, stable isotope labeling with amino acids in cell culture (SILAC) is performed, which is coupled with incorporation of alkyne-labeled linoleic acid (aLA). The cells are subsequently activated with Kdo2-lipidA to produce terminal alkyne labeled RES through lipid peroxidation [57]. After copper-mediated click chemistry, modified proteins are affinity purified and analyzed by MS.
Historically, the established methods to detect LDE modifications are based on bolus treatment, which may represent poorly the actual lipoxidation events occurring within cells, but in return can identify many RES sensors [54]. These methods use excess amounts of LDEs and can thus identify protein targets not encountered when more physiological levels of electrophiles are present [55]. Recently, novel methods with more sophisticated dosing and detection procedures have been introduced to reduce the inherent bias due to bolus dosing and to provide new means to quantitatively detect endogenous modifications [54], [56], [57], [58].
To avoid bolus treatment with a high concentration of LDEs, a method in which the LDE in question is delivered inside the cells as a photocaged precursor (Fig. 4B and C) and then liberated in situ to allow local delivery of LDE within cells has been developed [59]. The method can be coupled to proteomics to identify novel thiol targets in an unbiased manner [60] or to a specific signaling protein of interest [61]. Intriguingly, the method appears to produce modifications that have very little overlap with those evoked by external bolus addition. For instance, 4-HNE modified C513 and C518 within KEAP1, neither of which have been identified as sensitive cysteines in previous studies nor to have functional importance [3].
Also, methods to identify the modifications by endogenously produced lipid electrophiles need to be developed in order to address the (patho)physiological role of these in cellular processes. Beavers et al. combined stable isotope labeling with amino acids in cell culture, click chemistry, and ABPP techniques to explore adduction of lipid electrophiles endogenously generated during macrophage activation (Fig. 4D) [57]. In this study, mitochondria was identified as both the source and target of LDEs in activated macrophages, indicating the role of mitochondrial protein modifications in inflammatory diseases [57]. Similar approach has been used to identify targets of 12/15-Lipoxygenase (LOX-12/15) derived LDEs in macrophages [62]. It is enticing to speculate that LDEs could mediate also other stress responses and therefore it is necessary to expand the selection of stressors and cell types further.
6. Conclusions
It is now clear that reactive lipid electrophiles elicit signaling functions that are specific and biologically relevant, adding to the repertoire of post-translational modifications affecting cellular functions. Especially well studied are the KEAP1-NRF2 and HSR pathways, which have cytoprotective, anti-inflammatory and proteostatic functions (Fig. 5). While the techniques highlighted in this review will be important in elucidating novel targets in an unbiased manner, it is critical to identify which modifications ultimately have physiological relevance. Also, the methods that rely on the addition of exogenous lipid electrophile, either in bolus or intracellularly delivered, may not reflect a biologically meaningful situation. Therefore, the techniques to identify modifications by endogenously produced lipoxidation products need to be further developed, which in combination with unbiased omics approaches and functional studies will then reveal the biological relevance of findings.
Fig. 5.
Biological consequences of activation of KEAP1-NRF2 and HSF1 pathways by lipid-derived electrophiles. Both KEAP1-NRF2 and HSF1 pathways are modified with diverse set of exo- or endogenous compounds [19], [23], [40], [80], [81], [82], [83], [109], [110], [111]. In the light of maintaining redox-homeostasis, both pathways reduce proteotoxic stress and inflammation. There are evidences of cross-talk between these two pathways by certain compounds and also cross-protection by encoded genes during the course of their diverse signaling mechanisms. Reviewed: [112]. These pathways perform and maintain important cellular functions as well as some key regulatory effects, which make them interesting in the context of health and disease. The KEAP1-NRF2 pathway can modulate apoptosis [113], metabolic control [114], mitochondrial biogenesis [115] and critical steps in the development of organisms [105], [116], [117]. Like NRF2, HSF1 also has important role in the normal development [42], [118], regulation of normal chaperone machinery and glucose metabolism [119].
Funding sources and acknowledgement
The Academy of Finland (grant no.: 275147), Jane and Aatos Erkko Foundation, Sigrid Jusélius Foundation and Finnish Cancer Organizations (A-L.L) supported this work.
References
- 1.Sies H., Berndt C., Jones D.P. Oxidative stress. Annu. Rev. Biochem. 2017;86:715–748. doi: 10.1146/annurev-biochem-061516-045037. [DOI] [PubMed] [Google Scholar]
- 2.Schopfer F.J., Cipollina C., Freeman B.A. Formation and signaling actions of electrophilic lipids. Chem. Rev. 2011;111:5997–6021. doi: 10.1021/cr200131e. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Parvez S., Long M.J.C., Poganik J.R., Aye Y. Redox signaling by reactive electrophiles and oxidants. Chem. Rev. 2018;118:8798–8888. doi: 10.1021/acs.chemrev.7b00698. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Oeste C.L., Pérez-Sala D. Modification of cysteine residues by cyclopentenone prostaglandins: interplay with redox regulation of protein function. Mass Spectrom. Rev. 2014;33:110–125. doi: 10.1002/mas.21383. [DOI] [PubMed] [Google Scholar]
- 5.Vasil’Ev Y.V., Tzeng S.C., Huang L., Maier C.S. Protein modifications by electrophilic lipoxidation products: adduct formation, chemical strategies and tandem mass spectrometry for their detection and identification. Mass Spectrom. Rev. 2014;33:157–182. doi: 10.1002/mas.21389. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Levonen A.L., Dickinson D.A., Moellering D.R., Timothy Mulcahy R., Forman H.J., Darley-Usmar V.M. Biphasic effects of 15-deoxy-Δ12,14-prostaglandin J2 on glutathione induction and apoptosis in human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2001;21:1846–1851. doi: 10.1161/hq1101.098488. [DOI] [PubMed] [Google Scholar]
- 7.Martínez A.E., Sánchez-Gómez F.J., Díez-Dacal B., Oeste C.L., Pérez-Sala D. 15-deoxy-Δ12,14-prostaglandin J2 exerts pro- and anti-inflammatory effects in mesangial cells in a concentration-dependent manner. Inflamm. Allergy Drug Targets. 2012;11:58–65. doi: 10.2174/187152812798889349. [DOI] [PubMed] [Google Scholar]
- 8.Kansanen E., Kuosmanen S.M., Leinonen H., Levonenn A.L. The Keap1-Nrf2 pathway: mechanisms of activation and dysregulation in cancer. Redox Biol. 2013;1:45–49. doi: 10.1016/j.redox.2012.10.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Richter K., Haslbeck M., Buchner J. The heat shock response: life on the verge of death. Mol. Cell. 2010;40:253–266. doi: 10.1016/j.molcel.2010.10.006. [DOI] [PubMed] [Google Scholar]
- 10.Uchida K., Shiraishi M., Naito Y., Torii Y., Nakamura Y., Osawa T. Activation of stress signaling pathways by the end product of lipid peroxidation: 4-hydroxy-2-nonenal is a potential inducer of intracellular peroxide production. J. Biol. Chem. 1999;274:2234–2242. doi: 10.1074/jbc.274.4.2234. [DOI] [PubMed] [Google Scholar]
- 11.Cuadrado A., Nebreda A.R. Mechanisms and functions of p38 MAPK signalling. Biochem. J. 2010;429:403–417. doi: 10.1042/BJ20100323. [DOI] [PubMed] [Google Scholar]
- 12.Garzón B., Oeste C.L., Díez-Dacal B., Pérez-Sala D. Proteomic studies on protein modification by cyclopentenone prostaglandins: expanding our view on electrophile actions. J. Proteom. 2011;74:2243–2263. doi: 10.1016/j.jprot.2011.03.028. [DOI] [PubMed] [Google Scholar]
- 13.Suzuki T., Yamamoto M. Stress-sensing mechanisms and the physiological roles of the Keap1–Nrf2 system during cellular stress. J. Biol. Chem. 2017;292:16817–16824. doi: 10.1074/jbc.R117.800169. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Cuadrado A., Rojo A.I., Wells G., Hayes J.D., Cousin S.P., Rumsey W.L., Attucks O.C., Franklin S., Levonen A.-L., Kensler T.W., Dinkova- Kostova A.T. Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. Nat. Rev. Drug Discov. 2018 doi: 10.1038/s41573-018-0008-x. In Press. [DOI] [PubMed] [Google Scholar]
- 15.Kobayashi A., Kang M.-I., Okawa H., Ohtsuji M., Zenke Y., Chiba T., Igarashi K., Yamamoto M. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell. Biol. 2004;24:7130–7139. doi: 10.1128/MCB.24.16.7130-7139.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Kensler T.W., Wakabayashi N., Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu. Rev. Pharmacol. Toxicol. 2007;47:89–116. doi: 10.1146/annurev.pharmtox.46.120604.141046. [DOI] [PubMed] [Google Scholar]
- 17.Dinkova-Kostova A.T., Kostov R.V., Canning P. Keap1, the cysteine-based mammalian intracellular sensor for electrophiles and oxidants. Arch. Biochem. Biophys. 2017;617:84–93. doi: 10.1016/j.abb.2016.08.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Canning P., Sorrell F.J., Bullock A.N. Structural basis of Keap1 interactions with Nrf2. Free Radic. Biol. Med. 2015;88:101–107. doi: 10.1016/j.freeradbiomed.2015.05.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Saito R., Suzuki T., Hiramoto K., Asami S., Naganuma E., Suda H., Iso T., Yamamoto H., Morita M., Furusawa Y., Negishi T., Ichinose M., Yamamoto M. Characterizations of three major cysteine sensors of Keap1 in stress response. Mol. Cell. Biol. 2016;36:271–284. doi: 10.1128/MCB.00868-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Cipollina C. Endogenous generation and signaling actions of omega-3 fatty acid electrophilic derivatives. BioMed. Res. Int. 2015;2015 doi: 10.1155/2015/501792. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Dayalan Naidu S., Muramatsu A., Saito R., Asami S., Honda T., Hosoya T., Itoh K., Yamamoto M., Suzuki T., Dinkova-Kostova A.T. C151 in KEAP1 is the main cysteine sensor for the cyanoenone class of NRF2 activators, irrespective of molecular size or shape. Sci. Rep. 2018;8 doi: 10.1038/s41598-018-26269-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Jyrkkänen H.K., Kansanen E., Inkala M., Kivela A.M., Hurttila H., Heinonen S.E., Goldsteins G., Jauhiainen S., Tiainen S., Makkonen H., Oskolkova O., Afonyushkin T., Koistinaho J., Yamamoto M., Bochkov V.N., Ylä-Herttuala S., Levonen A.L. Nrf2 regulates antioxidant gene expression evoked by oxidized phospholipids in endothelial cells and murine arteries in vivo. Circ. Res. 2008;103 doi: 10.1161/CIRCRESAHA.108.176883. [DOI] [PubMed] [Google Scholar]
- 23.Li R., Chen W., Yanes R., Lee S., Berliner J.A. OKL38 is an oxidative stress response gene stimulated by oxidized phospholipids. J. Lipid Res. 2007;48:709–715. doi: 10.1194/jlr.M600501-JLR200. [DOI] [PubMed] [Google Scholar]
- 24.Bochkov V.N., Oskolkova O.V., Birukov K.G., Levonen A.-L., Binder C.J., Stöckl J. Generation and biological activities of oxidized phospholipids. Antioxid. Redox Signal. 2010;12:1009–1059. doi: 10.1089/ars.2009.2597. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Dokladny K., Myers O.B., Moseley P.L. Heat shock response and autophagy—cooperation and control. Autophagy. 2015;11:200–213. doi: 10.1080/15548627.2015.1009776. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Mahat D.B., Salamanca H.H., Duarte F.M., Danko C.G., Lis J.T. Mammalian heat shock response and mechanisms underlying its genome-wide transcriptional regulation. Mol. Cell. 2016;62:63–78. doi: 10.1016/j.molcel.2016.02.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Vihervaara A., Sistonen L. HSF1 at a glance. J. Cell Sci. 2014;127:261–266. doi: 10.1242/jcs.132605. [DOI] [PubMed] [Google Scholar]
- 28.Vihervaara A., Sergelius C., Vasara J., Blom M.A.H., Elsing A.N., Roos-Mattjus P., Sistonen L. Transcriptional response to stress in the dynamic chromatin environment of cycling and mitotic cells. Proc. Natl. Acad. Sci. USA. 2013;110:E3388–E3397. doi: 10.1073/pnas.1305275110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Dayalan Naidu S., Dinkova-Kostova A.T. Regulation of the mammalian heat shock factor 1. FEBS J. 2017;284:1606–1627. doi: 10.1111/febs.13999. [DOI] [PubMed] [Google Scholar]
- 30.Baler R., Dahl G., Voellmy R. Activation of human heat shock genes is accompanied by oligomerization, modification, and rapid translocation of heat shock transcription factor HSF1. Mol. Cell. Biol. 1993;13:2486–2496. doi: 10.1128/mcb.13.4.2486. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Zuo J., Baler R., Dahl G., Voellmyl R. Activation of the DNA-binding ability of human heat shock transcription factor 1 may involve the transition from an intramolecular to an intermolecular triple-stranded coiled-coil structure. Mol. Cell. Biol. 1994;14:7557–7568. doi: 10.1128/mcb.14.11.7557. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Sorger P.K., Nelson H.C.M. Trimerization of a yeast transcriptional activator via a coiled-coil motif. Cell. 1989;59:807–813. doi: 10.1016/0092-8674(89)90604-1. [DOI] [PubMed] [Google Scholar]
- 33.Łuczaj W., Gęgotek A., Skrzydlewska E. Antioxidants and HNE in redox homeostasis. Free Radic. Biol. Med. 2017;111:87–101. doi: 10.1016/j.freeradbiomed.2016.11.033. [DOI] [PubMed] [Google Scholar]
- 34.Kansanen E., Jyrkkänen H.K., Volger O.L., Leinonen H., Kivelä A.M., Häkkinen S.K., Woodcock S.R., Schopfer F.J., Horrevoets A.J., Ylä-Herttuala S., Freeman B.A., Levonen A.L. Nrf2-dependent and -independent responses to nitro-fatty acids in human endothelial cells: identification of heat shock response as the major pathway activated by nitro-oleic acid. J. Biol. Chem. 2009;284:33233–33241. doi: 10.1074/jbc.M109.064873. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Jacobs A.T., Marnett L.J. Heat shock factor 1 attenuates 4-hydroxynonenal-mediated apoptosis: critical role for heat shock protein 70 induction and stabilization of Bcl-XL. J. Biol. Chem. 2007;282:33412–33420. doi: 10.1074/jbc.M706799200. [DOI] [PubMed] [Google Scholar]
- 36.Santoro M.G., Garaci E., Amici C. Prostaglandins with antiproliferative activity induce the synthesis of a heat shock protein in human cells. Proc. Natl. Acad. Sci. USA. 1989;86:8407–8411. doi: 10.1073/pnas.86.21.8407. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Jacobs A.T., Marnett L.J. HSF1-mediated BAG3 expression attenuates apoptosis in 4-hydroxynonenal-treated colon cancer cells via stabilization of anti-apoptotic Bcl-2 proteins. J. Biol. Chem. 2009;284:9176–9183. doi: 10.1074/jbc.M808656200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Jacobs A.T., Marnett L.J. Systems analysis of protein modification and cellular responses induced by electrophile stress. Acc. Chem. Res. 2010;43:673–683. doi: 10.1021/ar900286y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Doyle K., Fitzpatrick F.A. Redox signaling, alkylation (carbonylation) of conserved cysteines inactivates class I histone deacetylases 1, 2, and 3 and antagonizes their transcriptional repressor function. J. Biol. Chem. 2010;285:17417–17424. doi: 10.1074/jbc.M109.089250. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Carbone D.L., Doorn J.A., Kiebler Z., Sampey B.P., Petersen D.R. Inhibition of Hsp72-mediated protein refolding by 4-hydroxy-2-nonenal. Chem. Res. Toxicol. 2004;17:1459–1467. doi: 10.1021/tx049838g. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Carbone D.L., Doorn J.A., Kiebler Z., Ickes B.R., Petersen D.R. Modification of heat shock protein 90 by 4-hydroxynonenal in a rat model of chronic alcoholic liver disease. J. Pharmacol. Exp. Theurapeutics. 2005;315:8–15. doi: 10.1124/jpet.105.088088. [DOI] [PubMed] [Google Scholar]
- 42.Ahn S.-G., Thiele D.J. Redox regulation of mammalian heat shock factor 1 is essential for Hsp gene activation and protection from stress. Genes Dev. 2003;17:516–528. doi: 10.1101/gad.1044503. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Connor R.E., Marnett L.J., Liebler D.C. Protein-selective capture to analyze electrophile adduction of Hsp90 by 4-hydroxynonenal. Chem. Res. Toxicol. 2011;24:1275–1282. doi: 10.1021/tx200157t. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Stamatakis K. Identification of novel protein targets for modification by 15-deoxy-Δ12,14-prostaglandin J2 in mesangial cells reveals multiple interactions with the cytoskeleton. J. Am. Soc. Nephrol. 2005;17:89–98. doi: 10.1681/ASN.2005030329. [DOI] [PubMed] [Google Scholar]
- 45.Garzón B., Gayarre J., Gharbi S., Díez-Dacal B., Sánchez-Gómez F.J., Timms J.F., Pérez-Sala D. A biotinylated analog of the anti-proliferative prostaglandin A1 allows assessment of PPAR-independent effects and identification of novel cellular targets for covalent modification. Chem.-Biol. Interact. 2010;183:212–221. doi: 10.1016/j.cbi.2009.09.019. [DOI] [PubMed] [Google Scholar]
- 46.Charles R.L., Burgoyne J.R., Mayr M., Weldon S.M., Hubner N., Dong H., Morisseau C., Hammock B.D., Landar A., Eaton P. Redox regulation of soluble epoxide hydrolase by 15-deoxy-Δ-prostaglandin J2 controls coronary hypoxic vasodilation. Circ. Res. 2011;108:324–334. doi: 10.1161/CIRCRESAHA.110.235879. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Aldini G., Regazzoni L., Orioli M., Rimoldi I., Facino R.M., Carini M. A tandem MS precursor-ion scan approach to identify variable covalent modification of albumin Cys34: a new tool for studying vascular carbonylation. J. Mass Spectrom. 2008;43:1470–1481. doi: 10.1002/jms.1419. [DOI] [PubMed] [Google Scholar]
- 48.Aldini G., Domingues M.R., Spickett C.M., Domingues P., Altomare A., Sánchez-Gómez F.J., Oeste C.L., Pérez-Sala D. Protein lipoxidation: detection strategies and challenges. Redox Biol. 2015;5:253–266. doi: 10.1016/j.redox.2015.05.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Levonen A.-L., Landar A., Ramachandran A., Ceaser E.K., Dickinson D.A., Zanoni G., Morrow J.D., Darley-Usmar V.M. Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products. Biochem. J. 2004;378:373–382. doi: 10.1042/BJ20031049. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Aldini G., Carini M., Vistoli G., Shibata T., Kusano Y., Gamberoni L., Dalle-Donne I., Milzani A., Uchida K. Identification of actin as a 15-deoxy-Δ12,14-prostaglandin J2 target in neuroblastoma cells: mass spectrometric, computational, and functional approaches to investigate the effect on cytoskeletal derangement. Biochemistry. 2007;46:2707–2718. doi: 10.1021/bi0618565. [DOI] [PubMed] [Google Scholar]
- 51.Aluise C.D., Camarillo J.M., Shimozu Y., Galligan J.J., Rose K.L., Tallman K.A., Marnett L.J. Site-specific, intramolecular cross-linking of pin1 active site residues by the lipid electrophile 4-oxo-2-nonenal. Chem. Res. Toxicol. 2015;28:817–827. doi: 10.1021/acs.chemrestox.5b00038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Vila A., Tallman K.A., Jacobs A.T., Liebler D.C., Porter N.A., Marnett L.J. Identification of protein targets of 4-hydroxynonenal using click chemistry for ex vivo biotinylation of azido and alkynyl derivatives. Chem. Res. Toxicol. 2008;21:432–444. doi: 10.1021/tx700347w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Wang C., Weerapana E., Blewett M.M., Cravatt B.F. A chemoproteomic platform to quantitatively map targets of lipid-derived electrophiles. Nat. Methods. 2014;11:79–85. doi: 10.1038/nmeth.2759. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Fang X., Fu Y., Long M.J.C., Haegele J.A., Ge E.J., Parvez S., Aye Y. Temporally controlled targeting of 4-hydroxynonenal to specific proteins in living cells. J. Am. Chem. Soc. 2013;135:14496–14499. doi: 10.1021/ja405400k. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Liu X., Long M.J.C., Aye Y. Proteomics and beyond: cell decision-making shaped by reactive electrophiles. Trends Biochem. Sci. 2018 doi: 10.1016/j.tibs.2018.09.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Los G.V., Encell L.P., McDougall M.G., Hartzell D.D., Karassina N., Zimprich C., Wood M.G., Learish R., Ohana R.F., Urh M., Simpson D., Mendez J., Zimmerman K., Otto P., Vidugiris G., Zhu J., Darzins A., Klaubert D.H., Bulleit R.F., Wood K.V. HaloTag: a novel protein labeling technology for cell imaging and protein analysis. ACS Chem. Biol. 2008;3:373–382. doi: 10.1021/cb800025k. [DOI] [PubMed] [Google Scholar]
- 57.Beavers W.N., Rose K.L., Galligan J.J., Mitchener M.M., Rouzer C.A., Tallman K.A., Lamberson C.R., Wang X., Hill S., Ivanova P.T., Brown H.A., Zhang B., Porter N.A., Marnett L.J. Protein modification by endogenously generated lipid electrophiles: mitochondria as the source and target. ACS Chem. Biol. 2017;12:2062–2069. doi: 10.1021/acschembio.7b00480. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Parvez S., Long M.J.C., Lin H.Y., Zhao Y., Haegele J.A., Pham V.N., Lee D.K., Aye Y. T-REX on-demand redox targeting in live cells. Nat. Protoc. 2016;11:2328–2356. doi: 10.1038/nprot.2016.114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Long M.J.C., Aye Y. The die is cast: precision electrophilic modifications contribute to cellular decision making. Chem. Res. Toxicol. 2016;29:1575–1582. doi: 10.1021/acs.chemrestox.6b00261. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Zhao Y., Long M.J.C., Wang Y., Zhang S., Aye Y. Ube2V2 is a Rosetta Stone Bridging Redox and Ubiquitin Codes, coordinating DNA damage responses. ACS Cent. Sci. 2018;4:246–259. doi: 10.1021/acscentsci.7b00556. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Parvez S., Fu Y., Li J., Long M.J.C., Lin H.Y., Lee D.K., Hu G.S., Aye Y. Substoichiometric hydroxynonenylation of a single protein recapitulates whole-cell-stimulated antioxidant response. J. Am. Chem. Soc. 2015;137:10–13. doi: 10.1021/ja5084249. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Isobe Y., Kawashima Y., Ishihara T., Watanabe K., Ohara O., Arita M. Identification of protein targets of 12/15-lipoxygenase-derived lipid electrophiles in mouse peritoneal macrophages using omega-alkynyl fatty acid. ACS Chem. Biol. 2018;13:887–893. doi: 10.1021/acschembio.7b01092. [DOI] [PubMed] [Google Scholar]
- 63.Talalay P., De Long M.J., Prochaska H.J. Identification of a common chemical signal regulating the induction of enzymes that protect against chemical carcinogenesis. Proc. Natl. Acad. Sci. USA. 1988;85:8261–8265. doi: 10.1073/pnas.85.21.8261. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Venugopal R., Jaiswal A.K. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase 1 gene. Proc. Natl. Acad. Sci. USA. 1996;93:14960–14965. doi: 10.1073/pnas.93.25.14960. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Tissiéres A., Mitchell H.K., Tracy U.M. Protein synthesis in salivary glands of Drosophila melanogaster: relation to chromosome puffs. J. Mol. Biol. 1974;84 doi: 10.1016/0022-2836(74)90447-1. [DOI] [PubMed] [Google Scholar]
- 66.Dinkova-Kostova A.T., Holtzclaw W.D., Cole R.N., Itoh K., Wakabayashi N., Katoh Y., Yamamoto M., Talalay P. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc. Natl. Acad. Sci. USA. 2002;99:11908–11913. doi: 10.1073/pnas.172398899. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Ali A., Bharadwaj S., O’Carroll R., Ovsenek N. HSP90 interacts with and regulates the activity of heat shock factor 1 in Xenopus oocytes. Mol. Cell. Biol. 1998;18:4949–4960. doi: 10.1128/mcb.18.9.4949. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Shi Y., Mosser D.D., Morimoto R.I. Molecular chaperones as HSF1-specific transcriptional repressors. Genes Dev. 1998;12:654–666. doi: 10.1101/gad.12.5.654. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Morimoto R.I. Regulation of the heat shock transcriptional response: cross talk between a family of heat shock factors, molecular chaperones, and negative regulators. Genes Dev. 1998;12:3788–3796. doi: 10.1101/gad.12.24.3788. [DOI] [PubMed] [Google Scholar]
- 70.Trinklein N.D., Murray J.I., Hartman S.J., Botstein D., Myers R.M. The role of heat shock transcription factor 1 in the genome-wide regulation of the mammalian heat shock response. Mol. Biol. Cell. 2004;15:1254–1261. doi: 10.1091/mbc.E03-10-0738. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Itoh K., Wakabayashi N., Katoh Y., Ishii T., Igarashi K., Engel J.D., Yamamoto M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 1999;13:76–86. doi: 10.1101/gad.13.1.76. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.He X., Ma Q. NRF2 cysteine residues are critical for oxidant/electrophile-sensing, Kelch-like ECH-associated protein-1-dependent ubiquitination-proteasomal degradation, and transcription activation. Mol. Pharmacol. 2009;76:1265–1278. doi: 10.1124/mol.109.058453. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Xu Q., Hu Y., Kleindienst R., Wick G. Nitric oxide induces heat-shock protein 70 expression in vascular smooth muscle cells via activation of heat shock factor 1. J. Clin. Investig. 1997;100:1089–1097. doi: 10.1172/JCI119619. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Lu M., Kim H.E., Li C.R., Kim S., Kwak I.J., Lee Y.J., Kim S.S., Moon J.Y., Cho H.K., Kim D.K., Ho S.K., Park J.S. Two distinct disulfide bonds formed in human heat shock transcription factor 1 act in opposition to regulate its DNA binding activity. Biochemistry. 2008;47:6007–6015. doi: 10.1021/bi702185u. [DOI] [PubMed] [Google Scholar]
- 75.Lindquist S. The heat-shock response. Annu. Rev. Biochem. 1986;55:1151–1191. doi: 10.1146/annurev.bi.55.070186.005443. [DOI] [PubMed] [Google Scholar]
- 76.Sandqvist A., Björk J.K., Akerfelt M., Chitikova Z., Grichine A., Vourc’h C., Jolly C., S.T. A, Nymalm Y., Sistonen L. Heterotrimerization of heat-shock factors 1 and 2 provides a transcriptional switch in response to distinct stimuli. Seikagaku. 2009;20:1340–1347. doi: 10.1091/mbc.E08-08-0864. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Martinez-Ruiz A., Villanueva L., de Orduna C.G., Lopez-Ferrer D., Higueras M.A., Tarin C., Rodriguez-Crespo I., Vazquez J., Lamas S. S-nitrosylation of Hsp90 promotes the inhibition of its ATPase and endothelial nitric oxide synthase regulatory activities. Proc. Natl. Acad. Sci. USA. 2005;102:8525–8530. doi: 10.1073/pnas.0407294102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Snyder G.H., Cennerazzo M.J., Karalis A.J., Field D. Electrostatic influence of local cysteine environments on disulfide exchange kinetics. Biochemistry. 1981;20:6509–6519. doi: 10.1021/bi00526a001. [DOI] [PubMed] [Google Scholar]
- 79.Borges C.R., Sherma N.D. Techniques for the analysis of cysteine sulfhydryls and oxidative protein folding. Antioxid. Redox Signal. 2014;21:511–531. doi: 10.1089/ars.2013.5559. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Villacorta L., Minarrieta L., Salvatore S.R., Khoo N.K., Rom O., Gao Z., Berman R.C., Jobbagy S., Li L., Woodcock S.R., Chen Y.E., Freeman B.A., Ferreira A.M., Schopfer F.J., Vitturi D.A. In situ generation, metabolism and immunomodulatory signaling actions of nitro-conjugated linoleic acid in a murine model of inflammation. Redox Biol. 2018 doi: 10.1016/j.redox.2018.01.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.McMahon M., Lamont D.J., Beattie K.A., Hayes J.D. Keap1 perceives stress via three sensors for the endogenous signaling molecules nitric oxide, zinc, and alkenals. Proc. Natl. Acad. Sci. USA. 2010;107:18838–18843. doi: 10.1073/pnas.1007387107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Kobayashi M., Li L., Iwamoto N., Nakajima-Takagi Y., Kaneko H., Nakayama Y., Eguchi M., Wada Y., Kumagai Y., Yamamoto M. The antioxidant defense system Keap1-Nrf2 comprises a multiple sensing mechanism for responding to a wide range of chemical compounds. Mol. Cell. Biol. 2009;29:493–502. doi: 10.1128/MCB.01080-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Villacorta L., Zhang J., Garcia-Barrio M.T., Chen X., Freeman B.a., Chen Y.E., Cui T. Nitro-linoleic acid inhibits vascular smooth muscle cell proliferation via the Keap1/Nrf2 signaling pathway. Am. J. Physiol. Heart Circ. Physiol. 2007;293:H770–H776. doi: 10.1152/ajpheart.00261.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Na H.K., Surh Y.J. Transcriptional regulation via cysteine thiol modification: a novel molecular strategy for chemoprevention and cytoprotection. Mol. Carcinog. 2006:368–380. doi: 10.1002/mc.20225. [DOI] [PubMed] [Google Scholar]
- 85.Li W., Yu S., Liu T., Kim J.H., Blank V., Li H., Kong A.N.T. Heterodimerization with small Maf proteins enhances nuclear retention of Nrf2 via masking the NESzip motif. Biochim. Et. Biophys. Acta - Mol. Cell Res. 2008;1783:1847–1856. doi: 10.1016/j.bbamcr.2008.05.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Belinsky M., Jaiswal A.K. NAD(P)H:Quinoneoxidoreductase1 (DT-diaphorase) expression in normal and tumor tissues. Cancer Metastasis Rev. 1993;12:103–117. doi: 10.1007/BF00689804. [DOI] [PubMed] [Google Scholar]
- 87.Chen H., Lum A., Seifried A., Wilkens L.R., Le Marchand L. Association of the NAD(P)H:quinone oxidoreductase609C→T polymorphism with a decreased lung cancer risk. Cancer Res. 1999;59:3045–3048. [PubMed] [Google Scholar]
- 88.Hou L., Chatterjee N., Huang W.-Y., Baccarelli A., Yadavalli S., Yeager M., Bresalier R.S., Chanock S.J., Caporaso N.E., Ji B.-T., Weissfeld J.L., Hayes R.B. CYP1A1 Val462 and NQO1 Ser187 polymorphisms, cigarette use, and risk for colorectal adenoma. Carcinogenesis. 2005;26 doi: 10.1093/carcin/bgi054. [DOI] [PubMed] [Google Scholar]
- 89.Šarmanová J., Šůsová S., Gut I., Mrhalová M., Kodet R., Adámek J., Roth Z., Souček P. Breast cancer: role of polymorphisms in biotransformation enzymes. Eur. J. Hum. Genet. 2004;12:848–854. doi: 10.1038/sj.ejhg.5201249. [DOI] [PubMed] [Google Scholar]
- 90.Nebert D.W., Vasiliou V. Analysis of the glutathione S-transferase (GST) gene family. Hum. Genom. 2004;1:460. doi: 10.1186/1479-7364-1-6-460. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Sodani K., Patel A., Kathawala R.J., Chen Z.S. Multidrug resistance associated proteins in multindrung resistance. Chin. J. Cancer. 2012;31:58–72. doi: 10.5732/cjc.011.10329. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Meister A., Anderson M.E. Glutathine. Ann. Rev. Biochem. 1983 doi: 10.1146/annurev.bi.52.070183.003431. [DOI] [PubMed] [Google Scholar]
- 93.Chen Y., Shertzer H.G., Schneider S.N., Nebert D.W., Dalton T.P. Glutamate cysteine ligase catalysis: dependence on ATP and modifier subunit for regulation of tissue glutathione levels. J. Biol. Chem. 2005;280:33766–33774. doi: 10.1074/jbc.M504604200. [DOI] [PubMed] [Google Scholar]
- 94.Turanov A.A., Kehr S., Marino S.M., Yoo M.-H., Carlson B.A., Hatfield D.L., Gladyshev V.N. Mammalian thioredoxin reductase 1: roles in redox homoeostasis and characterization of cellular targets. Biochem. J. 2010;430:285–293. doi: 10.1042/BJ20091378. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Neumann C.A., Cao J., Manevich Y. Peroxiredoxin 1 and its role in cell signaling. Cell Cycle. 2009;8:4072–4078. doi: 10.4161/cc.8.24.10242. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Ding C., Fan X., Wu G. Peroxiredoxin 1 – an antioxidant enzyme in cancer. J. Cell. Mol. Med. 2017;21:193–202. doi: 10.1111/jcmm.12955. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Bahrami S., Drabløs F. Gene regulation in the immediate-early response process. Adv. Biol. Regul. 2016;62:37–49. doi: 10.1016/j.jbior.2016.05.001. [DOI] [PubMed] [Google Scholar]
- 98.Wang F., Bonam S.R., Schall N., Kuhn L., Hammann P., Chaloin O., Madinier J.B., Briand J.P., Page N., Muller S. Blocking nuclear export of HSPA8 after heat shock stress severely alters cell survival. Sci. Rep. 2018;8 doi: 10.1038/s41598-018-34887-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.Enriquez A.S., Rojo H.M., Bhatt J.M., Molugu S.K., Hildenbrand Z.L., Bernal R.A. The human mitochondrial Hsp60 in the APO conformation forms a stable tetradecameric complex. Cell Cycle. 2017;16:1309–1319. doi: 10.1080/15384101.2017.1321180. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Vjestica A., Zhang D., Liu J., Oliferenko S. Hsp70-Hsp40 chaperone complex functions in controlling polarized growth by repressing Hsf1-driven heat stress-associated transcription. PLoS Genet. 2013;9 doi: 10.1371/journal.pgen.1003886. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Betous R., Rey L., Wang G., Pillaire M.J., Puget N., Selves J., Biard D.S.F., Shin-Ya K., Vasquez K.M., Cazaux C., Hoffmann J.S. Role of TLS DNA polymerases eta and kappa in processing naturally occurring structured DNA in human cells. Mol. Carcinog. 2009;48:369–378. doi: 10.1002/mc.20509. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Virág L. Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies. Curr. Vasc. Pharmacol. 2005;3:209–214. doi: 10.2174/1570161054368625. [DOI] [PubMed] [Google Scholar]
- 103.Todorova T., Bock F.J., Chang P. Poly(ADP-ribose) polymerase-13 and RNA regulation in immunity and cancer. Trends Mol. Med. 2015;21:373–384. doi: 10.1016/j.molmed.2015.03.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104.Fujimoto M., Takii R., Takaki E., Katiyar A., Nakato R., Shirahige K., Nakai A. The HSF1-PARP13-PARP1 complex facilitates DNA repair and promotes mammary tumorigenesis. Nat. Commun. 2017;8 doi: 10.1038/s41467-017-01807-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105.Loboda A., Damulewicz M., Pyza E., Jozkowicz A., Dulak J. Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Cell. Mol. Life Sci. 2016;73:3221–3247. doi: 10.1007/s00018-016-2223-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 106.Pronk T.E., van der Veen J.W., Vandebriel R.J., van Loveren H., de Vink E.P., Pennings J.L.A. Comparison of the molecular topologies of stress-activated transcription factors HSF1, AP-1, NRF2, and NF-κB in their induction kinetics of HMOX1. BioSystems. 2014;124:75–85. doi: 10.1016/j.biosystems.2014.09.005. [DOI] [PubMed] [Google Scholar]
- 107.Chou Y.H., Ho F.M., Liu D.Z., Lin S.Y., Tsai L.H., Chen C.H., Ho Y.S., Hung L.F., Liang Y.C. The possible role of heat shock factor-1 in the negative regulation of heme oxygenase-1. Int. J. Biochem. Cell Biol. 2005;37:604–615. doi: 10.1016/j.biocel.2004.08.006. [DOI] [PubMed] [Google Scholar]
- 108.Dayalan Naidu S., Dikovskaya D., Gaurilcikaite E., Knatko E.V., Healy Z.R., Mohan H., Koh G., Laurell A., Ball G., Olagnier D., De La Vega L., Ganley I.G., Talalay P., Dinkova-Kostova A.T. Transcription factors NRF2 and HSF1 have opposing functions in autophagy. Sci. Rep. 2017;7 doi: 10.1038/s41598-017-11262-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 109.Kansanen E., Bonacci G., Schopfer F.J., Kuosmanen S.M., Tong K.I., Leinonen H., Woodcock S.R., Yamamoto M., Carlberg C., Ylä-Herttuala S., Freeman B.A., Levonen A.L. Electrophilic nitro-fatty acids activate Nrf2 by a Keap1 cysteine 151-independent mechanism. J. Biol. Chem. 2011;286:14019–14027. doi: 10.1074/jbc.M110.190710. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 110.Carbone D.L. Modification of heat shock protein 90 by 4-hydroxynonenal in a rat model of chronic alcoholic liver disease. J. Pharmacol. Exp. Ther. 2005;315:8–15. doi: 10.1124/jpet.105.088088. [DOI] [PubMed] [Google Scholar]
- 111.Cui T., Schopfer F.J., Zhang J., Chen K., Ichikawa T., Baker P.R.S., Batthyany C., Chacko B.K., Feng X., Patel R.P., Agarwal A., Freeman B.A., Chen Y.E. Nitrated fatty acids: endogenous anti-inflammatory signaling mediators. J. Biol. Chem. 2006;281:35686–35698. doi: 10.1074/jbc.M603357200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112.Dayalan Naidu S., Kostov R.V., Dinkova-Kostova A.T. Transcription factors Hsf1 and Nrf2 engage in crosstalk for cytoprotection. Trends Pharmacol. Sci. 2015;36:6–14. doi: 10.1016/j.tips.2014.10.011. [DOI] [PubMed] [Google Scholar]
- 113.Niture S.K., Jaiswal A.K. Nrf2 protein up-regulates antiapoptotic protein Bcl-2 and prevents cellular apoptosis. J. Biol. Chem. 2012;287:9873–9886. doi: 10.1074/jbc.M111.312694. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 114.Sykiotis G.P., Habeos I.G., Samuelson A.V., Bohmann D. The role of the antioxidant and longevity-promoting Nrf2 pathway in metabolic regulation. Curr. Opin. Clin. Nutr. Metab. Care. 2011;14:41–48. doi: 10.1097/MCO.0b013e32834136f2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115.Dinkova-Kostova A.T., Abramov A.Y. The emerging role of Nrf2 in mitochondrial function. Free Radic. Biol. Med. 2015;88:179–188. doi: 10.1016/j.freeradbiomed.2015.04.036. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 116.Suzuki T., Seki S., Hiramoto K., Naganuma E., Kobayashi E.H., Yamaoka A., Baird L., Takahashi N., Sato H., Yamamoto M. Hyperactivation of Nrf2 in early tubular development induces nephrogenic diabetes insipidus. Nat. Commun. 2017;8 doi: 10.1038/ncomms14577. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 117.Venugopal R., Jaiswal A.K. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene. Proc. Natl. Acad. Sci. USA. 1996;93:14960–14965. doi: 10.1073/pnas.93.25.14960. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 118.Åkerfelt M., Morimoto R.I., Sistonen L. Heat shock factors: integrators of cell stress, development and lifespan. Nat. Rev. Mol. Cell Biol. 2010;11:545–555. doi: 10.1038/nrm2938. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 119.Calderwood S.K. HSF1, A versatile factor in tumorogenesis. Curr. Mol. Med. 2012;12:1102–1107. doi: 10.2174/156652412803306675. [DOI] [PMC free article] [PubMed] [Google Scholar]